SCHEMBL20176674

SCHEMBL20176674

Cc1ccc(OCCO)nc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.44
KMT2A Q03164 1/20 0.44
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
IKBKB O14920 1/20 0.37
ALDH1A1 P00352 2/20 0.36
RECQL P46063 1/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PI4KA P42356 1/20 0.35
PIK3CG P48736 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
GAA P10253 1/20 0.35
PIK3C3 Q8NEB9 1/20 0.35
NR1I2 O75469 1/20 0.34
HTR7 P34969 1/20 0.34
MAOA P21397 1/20 0.33
RXRA P19793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20163502 0.81 THRB (0.41) THRBKMT2AIKBKBALDH1A1RECQL
SCHEMBL23640025 0.81 TSHR (0.46) NOS3NOS1NOS2ALDH1A1PIK3CD
SCHEMBL13564152 0.78 NCF1 (0.41) NOS3NOS1NOS2HTR7RXRA
SCHEMBL12903736 0.78 NOS3 (0.41) NOS3NOS1NOS2ALDH1A1RXRA
SCHEMBL25679564 0.77 MCHR1 (0.40) NOS3NOS1NOS2HTR7RXRA
SCHEMBL9936035 0.76 THRB (0.50) THRBKMT2AIKBKBALDH1A1RECQL
SCHEMBL9936303 0.74 THRB (0.49) THRBKMT2AIKBKBALDH1A1PIK3CD
SCHEMBL10842869 0.73 KMT2A (0.51) THRBKMT2ANOS3NOS2ALDH1A1
SCHEMBL13213422 0.73 THRB (0.47) THRBKMT2AIKBKBALDH1A1PIK3CD
SCHEMBL9936300 0.73 THRB (0.47) THRBKMT2AIKBKBPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141913-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE EISAI R & D MANAGEMENT CO., LTD. (JP) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141913-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE BRCA1, ESR2, ESR1 THRB 189/4885KMT2A 3295/4885NOS3 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.